https://www.zonebourse.com/cours/action/PLURI-INC-62637874/actualite/Pluri-est-choisie-comme-CDMO-par-Remedy-Cell-pour-la-fabrication-de-medicaments-derives-de-cellul-46203946/?utm_source=telegram&utm_medium=social&utm_campaign=share